Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score61
United States Fiscal year ends December CIK 0001601830
4.36
+10.38%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
4.36 on 9 Oct 2026
7 5 3 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $5.53 14 Oct 2025 $5.89 15 Oct 2025 $6.79 16 Oct 2025 $6.36 17 Oct 2025 $5.86 20 Oct 2025 $6.68 21 Oct 2025 $6.11 22 Oct 2025 $5.75 23 Oct 2025 $5.73 24 Oct 2025 $6.04 27 Oct 2025 $6.30 28 Oct 2025 $5.91 29 Oct 2025 $5.87 30 Oct 2025 $5.65 31 Oct 2025 $5.52 3 Nov 2025 $5.44 4 Nov 2025 $5.00 5 Nov 2025 $4.96 6 Nov 2025 $4.62 7 Nov 2025 $4.62 10 Nov 2025 $4.51 11 Nov 2025 $4.71 12 Nov 2025 $4.65 13 Nov 2025 $4.33 14 Nov 2025 $4.14 17 Nov 2025 $4.12 18 Nov 2025 $4.16 19 Nov 2025 $4.03 20 Nov 2025 $3.85 21 Nov 2025 $4.17 24 Nov 2025 $4.33 25 Nov 2025 $4.37 26 Nov 2025 $4.41 28 Nov 2025 $4.63 1 Dec 2025 $4.36 2 Dec 2025 $4.32 3 Dec 2025 $4.66 4 Dec 2025 $4.92 5 Dec 2025 $4.71 8 Dec 2025 $4.82 9 Dec 2025 $4.77 10 Dec 2025 $4.77 11 Dec 2025 $4.58 12 Dec 2025 $4.33 15 Dec 2025 $4.20 16 Dec 2025 $4.20 17 Dec 2025 $4.68 18 Dec 2025 $4.44 19 Dec 2025 $4.26 22 Dec 2025 $4.40 23 Dec 2025 $4.36 24 Dec 2025 $4.40 26 Dec 2025 $4.25 29 Dec 2025 $4.13 30 Dec 2025 $4.11 31 Dec 2025 $4.09 2 Jan 2026 $4.20 5 Jan 2026 $4.37 6 Jan 2026 $4.55 7 Jan 2026 $4.86 8 Jan 2026 $4.70 9 Jan 2026 $4.66 12 Jan 2026 $4.81 13 Jan 2026 $4.69 14 Jan 2026 $4.85 15 Jan 2026 $4.64 16 Jan 2026 $4.67 20 Jan 2026 $4.40 21 Jan 2026 $4.61 22 Jan 2026 $4.96 23 Jan 2026 $4.73 26 Jan 2026 $4.59 27 Jan 2026 $4.60 28 Jan 2026 $4.47 29 Jan 2026 $4.32 30 Jan 2026 $4.19 2 Feb 2026 $4.18 3 Feb 2026 $4.10 4 Feb 2026 $3.90 5 Feb 2026 $3.56 6 Feb 2026 $3.98 9 Feb 2026 $3.98 10 Feb 2026 $3.85 11 Feb 2026 $3.71 12 Feb 2026 $3.58 13 Feb 2026 $3.49 17 Feb 2026 $3.46 18 Feb 2026 $3.53 19 Feb 2026 $3.72 20 Feb 2026 $3.42 23 Feb 2026 $3.41 24 Feb 2026 $3.53 25 Feb 2026 $3.77 26 Feb 2026 $3.77 27 Feb 2026 $3.67 2 Mar 2026 $3.63 3 Mar 2026 $3.54 4 Mar 2026 $3.64 5 Mar 2026 $3.54 6 Mar 2026 $3.46 9 Mar 2026 $3.51 10 Mar 2026 $3.44 11 Mar 2026 $3.45 12 Mar 2026 $3.29 13 Mar 2026 $3.42 16 Mar 2026 $3.39 17 Mar 2026 $3.42 18 Mar 2026 $3.32 19 Mar 2026 $3.37 20 Mar 2026 $3.25 23 Mar 2026 $3.23 24 Mar 2026 $3.17 25 Mar 2026 $3.17 26 Mar 2026 $3.15 27 Mar 2026 $2.94 30 Mar 2026 $2.84 31 Mar 2026 $3.07 1 Apr 2026 $3.06 2 Apr 2026 $3.11 6 Apr 2026 $3.15 7 Apr 2026 $3.19 8 Apr 2026 $3.39 9 Apr 2026 $3.31 10 Apr 2026 $3.28 13 Apr 2026 $3.42 14 Apr 2026 $3.54 15 Apr 2026 $3.75 16 Apr 2026 $3.60 17 Apr 2026 $3.78 20 Apr 2026 $3.69 21 Apr 2026 $3.56 22 Apr 2026 $3.73 23 Apr 2026 $3.50 24 Apr 2026 $3.51 27 Apr 2026 $3.48 28 Apr 2026 $3.41 29 Apr 2026 $3.30 30 Apr 2026 $3.46 1 May 2026 $3.39 4 May 2026 $3.52 5 May 2026 $3.37 6 May 2026 $3.43 7 May 2026 $3.27 8 May 2026 $3.32 11 May 2026 $3.26 12 May 2026 $3.15 13 May 2026 $3.05 14 May 2026 $3.04 15 May 2026 $2.93 18 May 2026 $2.89 19 May 2026 $2.85 20 May 2026 $2.96 21 May 2026 $3.11 22 May 2026 $3.01 26 May 2026 $2.97 27 May 2026 $3.17 28 May 2026 $3.44 29 May 2026 $3.59 1 Jun 2026 $3.79 2 Jun 2026 $3.61 3 Jun 2026 $3.47 4 Jun 2026 $3.80 5 Jun 2026 $3.32 8 Jun 2026 $3.32 9 Jun 2026 $3.22 10 Jun 2026 $3.04 11 Jun 2026 $3.15 12 Jun 2026 $3.15 15 Jun 2026 $3.29 16 Jun 2026 $3.18 17 Jun 2026 $3.11 18 Jun 2026 $3.23 22 Jun 2026 $3.18 23 Jun 2026 $3.16 24 Jun 2026 $3.23 25 Jun 2026 $3.34 26 Jun 2026 $3.52 29 Jun 2026 $3.69 30 Jun 2026 $3.67 1 Jul 2026 $3.67 2 Jul 2026 $3.80 6 Jul 2026 $3.96 7 Jul 2026 $3.84 8 Jul 2026 $3.72 9 Jul 2026 $3.76 10 Jul 2026 $3.56 13 Jul 2026 $3.30 14 Jul 2026 $3.34 15 Jul 2026 $3.31 16 Jul 2026 $3.02 17 Jul 2026 $2.95 20 Jul 2026 $2.89 21 Jul 2026 $3.08 22 Jul 2026 $2.98 23 Jul 2026 $3.01 24 Jul 2026 $2.96 27 Jul 2026 $3.01 28 Jul 2026 $3.05 29 Jul 2026 $2.97 30 Jul 2026 $3.04 31 Jul 2026 $3.00 3 Aug 2026 $3.18 4 Aug 2026 $3.31 5 Aug 2026 $3.17 6 Aug 2026 $3.18 7 Aug 2026 $3.22 10 Aug 2026 $3.29 11 Aug 2026 $3.35 12 Aug 2026 $3.29 13 Aug 2026 $3.31 14 Aug 2026 $3.16 17 Aug 2026 $3.11 18 Aug 2026 $3.09 19 Aug 2026 $3.50 20 Aug 2026 $3.34 21 Aug 2026 $3.50 24 Aug 2026 $3.25 25 Aug 2026 $3.56 26 Aug 2026 $3.49 27 Aug 2026 $3.44 28 Aug 2026 $3.34 31 Aug 2026 $3.40 1 Sep 2026 $3.33 2 Sep 2026 $3.38 3 Sep 2026 $3.44 4 Sep 2026 $3.63 8 Sep 2026 $3.44 9 Sep 2026 $3.22 10 Sep 2026 $3.16 11 Sep 2026 $3.20 14 Sep 2026 $3.41 15 Sep 2026 $3.24 16 Sep 2026 $3.19 17 Sep 2026 $3.54 18 Sep 2026 $3.83 21 Sep 2026 $3.97 22 Sep 2026 $4.05 23 Sep 2026 $3.70 24 Sep 2026 $3.89 25 Sep 2026 $3.74 28 Sep 2026 $3.70 29 Sep 2026 $4.03 30 Sep 2026 $4.13 1 Oct 2026 $4.07 2 Oct 2026 $4.12 5 Oct 2026 $4.78 6 Oct 2026 $4.63 7 Oct 2026 $4.27 8 Oct 2026 $3.95 9 Oct 2026 $4.36 Gibson Christopher Chief Executive Officer Sold on a plan $570.00K 23 Oct 2025 · at $5.70 · 9.5% of stake Gibson Christopher Chief Executive Officer Sold on a plan $208.40K 4 Nov 2025 · at $5.21 · 3.9% of stake Gibson Christopher Chief Executive Officer Sold on a plan $166.40K 19 Nov 2025 · at $4.16 · 4.2% of stake Borgeson Blake Director Sold on a plan $961.40K 2 Dec 2025 · at $4.37 · 3.1% of stake Gibson Christopher Chief Executive Officer Sold on a plan $185.20K 4 Dec 2025 · at $4.63 · 4.1% of stake Gibson Christopher Chief Executive Officer Sold on a plan $180.00K 19 Dec 2025 · at $4.50 · 4.2% of stake Khan Najat Chief R&D Commercial Officer Sold on a plan $548.59K 22 Dec 2025 · at $4.41 · 16.9% of stake Taylor Ben R Chief Financial Officer Sold on a plan $89.38K 29 Dec 2025 · at $4.18 · 2.7% of stake Gibson Christopher Director Sold on a plan $170.00K 5 Jan 2026 · at $4.25 · 4.1% of stake Borgeson Blake Director Sold on a plan $959.20K 6 Jan 2026 · at $4.36 · 3.2% of stake Gibson Christopher Director Sold on a plan $178.80K 20 Jan 2026 · at $4.47 · 4.2% of stake Borgeson Blake Director Sold on a plan $924.00K 3 Feb 2026 · at $4.20 · 3.3% of stake Gibson Christopher Director Sold on a plan $164.80K 4 Feb 2026 · at $4.12 · 4.2% of stake Taylor Ben R Chief Financial Officer Sold on a plan $41.35K 18 Feb 2026 · at $3.08 · 1.1% of stake Gibson Christopher Director Sold on a plan $138.40K 19 Feb 2026 · at $3.46 · 4.2% of stake Borgeson Blake Director Sold on a plan $588.20K 3 Mar 2026 · at $3.46 · 2.6% of stake Khan Najat CEO and President Sold on a plan $94.66K 9 Mar 2026 · at $3.35 · 1.2% of stake Taylor Ben R Chief Financial Officer Sold on a plan $26.97K 17 Mar 2026 · at $3.39 · 0.7% of stake Gibson Christopher Director Sold on a plan $130.00K 23 Mar 2026 · at $3.25 · 4.2% of stake Borgeson Blake Director Sold on a plan $93.00K 7 Apr 2026 · at $3.10 · 0.5% of stake Gibson Christopher Director Sold on a plan $124.00K 7 Apr 2026 · at $3.10 · 4.2% of stake Gibson Christopher Director Sold on a plan $144.40K 22 Apr 2026 · at $3.61 · 4.2% of stake Borgeson Blake Director Sold on a plan $105.60K 5 May 2026 · at $3.52 · 0.5% of stake Gibson Christopher Director Sold on a plan $134.80K 7 May 2026 · at $3.37 · 4.1% of stake Gibson Christopher Director Sold on a plan $123.20K 22 May 2026 · at $3.08 · 4.3% of stake Borgeson Blake Director Sold on a plan $110.40K 2 Jun 2026 · at $3.68 · 0.5% of stake Bumpus Namandje Director Sold on a plan $15.53K 3 Jun 2026 · at $3.54 · 9.2% of stake Khan Najat CEO and President Sold on a plan $84.46K 5 Jun 2026 · at $3.58 · 1.1% of stake Gibson Christopher Director Sold on a plan $144.80K 5 Jun 2026 · at $3.62 · 4.3% of stake Bumpus Namandje Director Sold on a plan $12.60K 18 Jun 2026 · at $3.18 · 3.0% of stake Borgeson Blake Director Sold on a plan $158.50K 7 Jul 2026 · at $3.96 · 0.6% of stake Borgeson Blake Director Sold on a plan $97.50K 4 Aug 2026 · at $3.25 · 0.5% of stake Borgeson Blake Director Sold on a plan $100.20K 1 Sep 2026 · at $3.34 · 0.5% of stake Khan Najat CEO and President Sold on a plan $78.82K 8 Sep 2026 · at $3.52 · 1.1% of stake HERSHBERG ROBERT Director Sold on a plan $125.00K 6 Oct 2026 · at $5.00 · 13.4% of stake Borgeson Blake Director Sold on a plan $242.00K 6 Oct 2026 · at $4.84 · 0.8% of stake
0 buys0 sales at will36 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$74.68M
Net income
$644.76M
Free cash flow
$378.28M
Operating margin
-867.9%
Net margin
-863.4%
Return on equity
-57.0%
Return on capital
-45.3%
Debt to equity
0.00
Revenue growth, 1 yr
26.9%
Revenue growth, 5 yr
79.9% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
4M -87M FY20 Fiscal year 2020 Revenue $3.96M Net income $87.01M Margin -2,196.0% 10M -186M FY21 Fiscal year 2021 Revenue $10.18M Net income $186.48M Margin -1,832.2% · growth +156.9% 40M -239M FY22 Fiscal year 2022 Revenue $39.84M Net income $239.48M Margin -601.0% · growth +291.5% 45M -328M FY23 Fiscal year 2023 Revenue $44.58M Net income $328.07M Margin -736.0% · growth +11.9% 59M -464M FY24 Fiscal year 2024 Revenue $58.84M Net income $463.66M Margin -788.0% · growth +32.0% 75M -645M FY25 Fiscal year 2025 Revenue $74.68M Net income $644.76M Margin -863.4% · growth +26.9%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
6 Oct 2026 Borgeson Blake
Director
Sold on a plan $242.00K 0.8%
6 Oct 2026 HERSHBERG ROBERT
Director
Sold on a plan $125.00K 13.4%
8 Sep 2026 Khan Najat
CEO and President
Sold on a plan $78.82K 1.1%
1 Sep 2026 Borgeson Blake
Director
Sold on a plan $100.20K 0.5%
4 Aug 2026 Borgeson Blake
Director
Sold on a plan $97.50K 0.5%
7 Jul 2026 Borgeson Blake
Director
Sold on a plan $158.50K 0.6%